Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricBSXBoston ScientificEWEdwards LifesciencesIDXXIdexx Laboratories
Snapshot
Price$49.39$91.23$543.68
Market cap$67.09B$54.34B$44.00B
Valuation
P/E20.6x47.9x39.2x
Forward P/E14.7x68.4x31.2x
Growth
Revenue growth17.4%13.8%13.1%
EPS growth74.7%-73.2%25.6%
Profitability
Net margin17.3%17.4%24.6%
ROE14.9%10.6%70.9%
Balance sheet & cash
Debt / equity0.47x0.06x0.53x
Free cash flow yield3.5%2.9%1.9%
Dividend yield———
Verdict
Investment ratingFavorable· 71Neutral· 47Favorable· 69

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBSXtoday $49EWtoday $91IDXXtoday $544
2027$64.72 – $94.92+92% CAGR$69.79 – $102.36+12% CAGR$512.11 – $751.09+38% CAGR
2028$113.08 – $165.85+83% CAGR$71.19 – $104.41+7% CAGR$643.15 – $943.29+32% CAGR
2029$197.57 – $289.77+80% CAGR$72.61 – $106.50+5% CAGR$807.74 – $1,184.68+30% CAGR
2030$345.20 – $506.29+79% CAGR$74.06 – $108.63+4% CAGR$1,014.44 – $1,487.84+29% CAGR
2031$603.13 – $884.60+78% CAGR$75.54 – $110.80+4% CAGR$1,274.03 – $1,868.58+28% CAGR
5-yr CAGR65.0% – 78.1%-3.7% – 4.0%18.6% – 28.0%